Advertisers here increased by 51%, fuelling platform revenue gains of 28%, which were further bolstered by the performance of its health-specific product, which also saw the number of advertisers climb by 51%.
According to its executive team, the solid figures were driven by its AI tool AXON 2.0, launched in Q2. Specifically, AXON 2.0 has been accredited with powering growth in user acquisition spend.
One of the powerhouses of retargeting, to many it seemed like an insurmountable goal to pivot the business when governments, Google, and the court of public opinion deemed the third-party cookie should be no more. However, like Hillary and Norgay, they have now climbed that big ol' hill, as they crossed the 50% threshold for non-retargeting revenues for the first time.
[
add
]
[
|
|
...
]